| Line Item | 2024-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.0M | — | +7.9% |
| Cost of Revenue | $5.6M | — | -59.1% |
| R&D Expense | $4.2M | — | -53.6% |
| SG&A Expense | $11.8M | — | -22.0% |
| Operating Income | -$14.0M | — | +57.8% |
| Pre-tax Income | -$13.6M | — | +58.6% |
| Income Tax | $2K | — |
| Line Item | 2024-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $108.6M | +14.7% | -6.9% |
| Accounts Receivable | $7.8M | +30.0% | -28.4% |
| Inventory | $10.5M | -36.8% | -54.4% |
| Current Assets | $202.8M | -14.4% | -19.5% |
| Total Assets | $263.6M | -10.5% | -8.4% |
| Current Liabilities |
| Line Item | 2024-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$31.1M | — | -20.9% |
| Capital Expenditures | $10K | — | +0.0% |
| Investing Cash Flow | $45.2M | — | +38.5% |
| Free Cash Flow | -$31.1M | — | -20.9% |
| -81.8% |
| Net Income | -$13.6M | — | +58.6% |
| EPS (Basic) | -$0.09 | — | +60.9% |
| EPS (Diluted) | -$0.09 | — | +60.9% |
| $76.4M |
| -19.0% |
| +80.3% |
| Total Liabilities | $106.0M | -15.4% | +42.4% |
| Stockholders' Equity | $157.6M | -6.8% | -26.1% |